PHARMAC - Latest News [Page 1]

Up to 3000 Women to Benefit from PHARMAC Decision

Thursday, 14 December 2017, 10:58 am | PHARMAC

Post-menopausal women with early breast cancer will soon be able to have funded zoledronic acid, to prevent the disease spreading into bones. More >>

Grant Winners Announced for New Research Fund

Thursday, 2 March 2017, 1:54 pm | PHARMAC

Researchers from Auckland and Otago Universities are the first recipients of new grants from PHARMAC and the Health Research Council of New Zealand (HRC). More >>

Proposals to widen funding access to important vaccines

Monday, 30 May 2016, 3:57 pm | PHARMAC

PHARMAC is asking the public for feedback on proposals to widen funding access to the varicella (chickenpox) and human papillomavirus (HPV) vaccines, as well as other changes to funded vaccines. More >>

PHARMAC’s new approach getting real traction

Tuesday, 17 May 2016, 10:12 am | PHARMAC

A new approach PHARMAC has used for funding medicines for rare disorders is gaining real traction, says chief executive Steffan Crausaz. More >>

More treatments funded for respiratory disease

Tuesday, 9 February 2016, 2:12 pm | PHARMAC

PHARMAC is funding six new medicines that will improve treatment options for people with Chronic Obstructive Pulmonary Disease (COPD). More >>

Rare disorders process yields first funding decision

Wednesday, 16 September 2015, 9:31 am | PHARMAC

People with the rare blood condition hereditary angioedema are the first to benefit from the increased competition for rare disorders medicines promoted by PHARMAC. More >>

Tender still important to maintain NZers’ access to medicine

Tuesday, 4 August 2015, 10:53 am | PHARMAC

Tender still important to maintain NZers’ access to medicines PHARMAC’s annual tender continues to achieve its objectives, freeing up nearly $45 million from the 2014/15 tender round to reinvest in more medicines for more New Zealanders. The tender ... More >>

Prostate cancer treatment to be funded from 1 May

Wednesday, 8 April 2015, 1:37 pm | PHARMAC

PHARMAC will begin funding for the prostate cancer treatment abiraterone (Zytiga) from 1 May 2015, potentially benefiting up to 1000 men annually. More >>

Savings from extended roles exceed $100m

Thursday, 11 December 2014, 2:05 pm | PHARMAC

District Health Boards are poised to save more than $100 million over five years as a result of PHARMAC’s expanded role, PHARMAC reports in its Annual Review, released today. More >>

New medicine funded to combat multi-resistant infections

Friday, 31 October 2014, 10:26 am | PHARMAC

New Zealand hospitals are about to strengthen their defences against multi-resistant bacterial infections with the funding of a new antibiotic. More >>

New medicines improve options for respiratory conditions

Monday, 20 October 2014, 2:33 pm | PHARMAC

PHARMAC decisions to fund four new medicines will improve treatment options for over 10,000 people with a wide range of respiratory conditions. More >>

Major step forward for multiple sclerosis treatment

Friday, 10 October 2014, 3:02 pm | PHARMAC

Funding for newer and more effective multiple sclerosis treatments has been approved by PHARMAC. About 600 people currently receive funded MS treatments. PHARMAC estimates this could grow by about 400 over the next few years, with the change in criteria ... More >>

Two new treatments funded for blood disorders and cancers

Wednesday, 20 August 2014, 10:56 am | PHARMAC

Up to 400 patients a year are likely to live longer as a result of PHARMAC funding two new medicines. More >>

 

InfoPages Links

 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL